To amend the Federal Food, Drug, and Cosmetic Act to provide...
To amend the Federal Food, Drug, and Cosmetic Act to provide for expedited approval of priority nonprescription drugs, and for other purposes.
This bill proposes to make changes to the Federal Food, Drug, and Cosmetic Act by allowing for quicker approval of certain nonprescription drugs that are considered a priority. These priority drugs are likely those that could significantly improve public health or treat urgent medical needs.
The bill would mainly affect the pharmaceutical industry, the FDA, and consumers who would benefit from faster access to important nonprescription medications. By expediting the approval process for priority drugs, the bill aims to ensure that these medications reach the market more quickly, potentially improving health outcomes.
As of July 20, 2026, the bill has been introduced and referred to the House Committee on Energy and Commerce. The next steps will involve committee review, potential amendments, and a vote before it can move forward in the legislative process.
